NCT06883201 Application of Patient Blood Management in the Oncology Patient Affected by Breast Cancer
| NCT ID | NCT06883201 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Regina Elena Cancer Institute |
| Condition | Breast Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 78 participants |
| Start Date | 2023-01-31 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 78 participants in total. It began in 2023-01-31 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evaluation of the percentage of transfusions in patients with breast cancer undergoing surgery after preventive treatment with haematinics.
Eligibility Criteria
Inclusion Criteria: * age \> 18 years; * patients diagnosed with histologically confirmed breast cancer and whether or not they have undergone neoadjuvant chemotherapy; * patients who are candidates for destructive and reconstructive breast surgery or not; * Hb values less than or equal to 11 g/dL and/or transferrin saturation less than or equal to 20%; * written informed consent. Exclusion Criteria: * patients with known allergies to ferric carboxymaltose or its excipients; * ferritin values greater than 500 ng/ml; * patients unable to sign consent and comply with procedures.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06883201 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06883201 currently recruiting?
Yes, NCT06883201 is actively recruiting participants. Contact the research team at giuseppina.natale@ifo.it for enrollment information.
Where is the NCT06883201 trial being conducted?
This trial is being conducted at Rome, Italy.
Who is sponsoring the NCT06883201 clinical trial?
NCT06883201 is sponsored by Regina Elena Cancer Institute. The trial plans to enroll 78 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.